{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:06:20Z","timestamp":1795071980611,"version":"4.10.2"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The risk of dementia is higher in women than men. The metabolic consequences of estrogen decline during menopause accelerate neuropathology in women. The use of hormone replacement therapy (HRT) in the prevention of cognitive decline has shown conflicting results. Here we investigate the modulating role of\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype and age at HRT initiation on the heterogeneity in cognitive response to HRT.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The analysis used baseline data from participants in the European Prevention of Alzheimer\u2019s Dementia (EPAD) cohort (total\n                      <jats:italic>n<\/jats:italic>\n                      = 1906, women= 1178, 61.8%). Analysis of covariate (ANCOVA) models were employed to test the independent and interactive impact of\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype and HRT on select cognitive tests, such as MMSE, RBANS, dot counting, Four Mountain Test (FMT), and the supermarket trolley test (SMT), together with volumes of the medial temporal lobe (MTL) regions by MRI. Multiple linear regression models were used to examine the impact of age of HRT initiation according to\n                      <jats:italic>APOE4<\/jats:italic>\n                      carrier status on these cognitive and MRI outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>APOE4<\/jats:italic>\n                      HRT users had the highest RBANS delayed memory index score (P-\n                      <jats:italic>APOE<\/jats:italic>\n                      *HRT interaction = 0.009) compared to\n                      <jats:italic>APOE4<\/jats:italic>\n                      non-users and to non-\n                      <jats:italic>APOE4<\/jats:italic>\n                      carriers, with 6\u201310% larger entorhinal (left) and amygdala (right and left) volumes (\n                      <jats:italic>P<\/jats:italic>\n                      -interaction= 0.002, 0.003, and 0.005 respectively). Earlier introduction of HRT was associated with larger right (standardized\n                      <jats:italic>\u03b2<\/jats:italic>\n                      = \u22120.555,\n                      <jats:italic>p<\/jats:italic>\n                      =0.035) and left hippocampal volumes (standardized\n                      <jats:italic>\u03b2<\/jats:italic>\n                      = \u22120.577,\n                      <jats:italic>p<\/jats:italic>\n                      =0.028) only in\n                      <jats:italic>APOE4<\/jats:italic>\n                      carriers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      HRT introduction is associated with improved delayed memory and larger entorhinal and amygdala volumes in\n                      <jats:italic>APOE4<\/jats:italic>\n                      carriers only. This may represent an effective targeted strategy to mitigate the higher life-time risk of AD in this large at-risk population subgroup. Confirmation of findings in a fit for purpose RCT with prospective recruitment based on\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype is needed to establish causality.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-022-01121-5","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T08:04:47Z","timestamp":1673251487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":146,"title":["Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer\u2019s Disease (EPAD) cohort"],"prefix":"10.1186","volume":"15","author":[{"given":"Rasha N. M.","family":"Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hornberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Minihane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"1121_CR1","doi-asserted-by":"crossref","unstructured":"2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17(3):327\u2013406.","DOI":"10.1002\/alz.12328"},{"issue":"1","key":"1121_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"E Nichols","year":"2019","unstructured":"Nichols E, Szoeke CEI, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, et al. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88\u2013106.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1121_CR3","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105\u2013e25.","journal-title":"Lancet Public Health"},{"issue":"9","key":"1121_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/13803395.2012.712676","volume":"34","author":"K Irvine","year":"2012","unstructured":"Irvine K, Laws KR, Gale TM, Kondel TK. Greater cognitive deterioration in women than men with Alzheimer's disease: a meta analysis. J Clin Exp Neuropsychol. 2012;34(9):989\u201398.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"1","key":"1121_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5498\/wjp.v6.i1.54","volume":"6","author":"KR Laws","year":"2016","unstructured":"Laws KR, Irvine K, Gale TM. Sex differences in cognitive impairment in Alzheimer's disease. World J Psychiatry. 2016;6(1):54\u201365.","journal-title":"World J Psychiatry"},{"key":"1121_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neurobiolaging.2018.05.017","volume":"69","author":"M Pontifex","year":"2018","unstructured":"Pontifex M, Vauzour D, Minihane AM. The effect of APOE genotype on Alzheimer's disease risk is influenced by sex and docosahexaenoic acid status. Neurobiol Aging. 2018;69:209\u201320.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1121_CR7","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1007\/s00018-021-03830-w","volume":"78","author":"D Zhu","year":"2021","unstructured":"Zhu D, Montagne A, Zhao Z. Alzheimer\u2019s pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci. 2021;78(11):4907\u201320.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1121_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molmed.2012.12.007","volume":"19","author":"J Cui","year":"2013","unstructured":"Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med. 2013;19(3):197\u2013209.","journal-title":"Trends Mol Med"},{"key":"1121_CR9","doi-asserted-by":"crossref","unstructured":"Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, et al. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Neurology. 2016;87(7):699-708.","DOI":"10.1212\/WNL.0000000000002980"},{"issue":"1","key":"1121_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12974-020-01998-9","volume":"17","author":"M McCarthy","year":"2020","unstructured":"McCarthy M, Raval AP. The peri-menopause in a woman\u2019s life: a systemic inflammatory phase that enables later neurodegenerative disease. J Neuroinflammation. 2020;17(1):317.","journal-title":"J Neuroinflammation"},{"issue":"17","key":"1121_CR11","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","volume":"288","author":"PP Zandi","year":"2002","unstructured":"Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA. 2002;288(17):2123\u20139.","journal-title":"JAMA."},{"issue":"7","key":"1121_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.288.7.872","volume":"288","author":"HD Nelson","year":"2002","unstructured":"Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal Hormone Replacement TherapyScientific Review. JAMA. 2002;288(7):872\u201381.","journal-title":"JAMA."},{"issue":"8","key":"1121_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","volume":"283","author":"RA Mulnard","year":"2000","unstructured":"Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA. 2000;283(8):1007\u201315.","journal-title":"JAMA"},{"issue":"7","key":"1121_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0002-9343(02)01270-6","volume":"113","author":"D Grady","year":"2002","unstructured":"Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen\/progestin Replacement Study. Am J Med. 2002;113(7):543\u20138.","journal-title":"Am J Med"},{"issue":"20","key":"1121_CR15","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","volume":"289","author":"SA Shumaker","year":"2003","unstructured":"Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651\u201362.","journal-title":"JAMA."},{"issue":"24","key":"1121_CR16","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","volume":"291","author":"SA Shumaker","year":"2004","unstructured":"Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal WomenWomen's Health Initiative Memory Study. JAMA. 2004;291(24):2947\u201358.","journal-title":"JAMA."},{"key":"1121_CR17","doi-asserted-by":"crossref","unstructured":"Zhou HH, Yu Z, Luo L, Xie F, Wang Y, Wan Z. The effect of hormone replacement therapy on cognitive function in healthy postmenopausal women: a meta-analysis of 23 randomized controlled trials. Psychogeriatrics. 2021;21(6):926\u201338.","DOI":"10.1111\/psyg.12768"},{"issue":"5","key":"1121_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neuron.2020.02.034","volume":"106","author":"N Zhao","year":"2020","unstructured":"Zhao N, Ren Y, Yamazaki Y, Qiao W, Li F, Felton LM, et al. Alzheimer\u2019s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways. Neuron. 2020;106(5):727\u201342.e6.","journal-title":"Neuron."},{"key":"1121_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neulet.2013.12.032","volume":"560","author":"J Kunzler","year":"2014","unstructured":"Kunzler J, Youmans KL, Yu C, Ladu MJ, Tai LM. APOE modulates the effect of estrogen therapy on A\u03b2 accumulation EFAD-Tg mice. Neurosci Lett. 2014;560:131\u20136.","journal-title":"Neurosci Lett"},{"issue":"16","key":"1121_CR20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA"},{"issue":"17","key":"1121_CR21","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jama.1994.03510410028015","volume":"271","author":"H Payami","year":"1994","unstructured":"Payami H, Montee KR, Kaye JA, Bird TD, Yu CE, Wijsman EM, et al. Alzheimer's disease, apolipoprotein E4, and gender. JAMA. 1994;271(17):1316\u20137.","journal-title":"JAMA."},{"issue":"1","key":"1121_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1212\/WNL.57.1.89","volume":"57","author":"EL Mortensen","year":"2001","unstructured":"Mortensen EL, H\u00f8gh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology. 2001;57(1):89\u201395.","journal-title":"Neurology."},{"issue":"4","key":"1121_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.neurobiolaging.2010.05.017","volume":"33","author":"MA Beydoun","year":"2012","unstructured":"Beydoun MA, Boueiz A, Abougergi MS, Kitner-Triolo MH, Beydoun HA, Resnick SM, et al. Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline. Neurobiol Aging. 2012;33(4):720\u201331.e4.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1121_CR24","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","volume":"74","author":"SC Neu","year":"2017","unstructured":"Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, et al. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. JAMA Neurol. 2017;74(10):1178\u201389.","journal-title":"JAMA Neurol"},{"key":"1121_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3233\/JAD-180859","volume":"71","author":"Z Hobel","year":"2019","unstructured":"Hobel Z, Isenberg AL, Raghupathy D, Mack W, Pa J, for the Alzheimer\u2019s Disease Neuroimaging I, et al. APOE \u025b4 Gene Dose and Sex Effects on Alzheimer\u2019s Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment. J Alzheimers Dis. 2019;71:647\u201358.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1121_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/GME.0b013e3182960cf8","volume":"20","author":"PM Maki","year":"2013","unstructured":"Maki PM. Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause. 2013;20(6):695\u2013709.","journal-title":"Menopause."},{"key":"1121_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neurobiolaging.2018.04.004","volume":"70","author":"DW Fisher","year":"2018","unstructured":"Fisher DW, Bennett DA, Dong H. Sexual dimorphism in predisposition to Alzheimer's disease. Neurobiol Aging. 2018;70:308\u201324.","journal-title":"Neurobiol Aging"},{"issue":"1-2","key":"1121_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jnr.23827","volume":"95","author":"CJ Pike","year":"2017","unstructured":"Pike CJ. Sex and the development of Alzheimer's disease. J Neurosci Res. 2017;95(1-2):671\u201380.","journal-title":"J Neurosci Res"},{"issue":"18","key":"1121_CR29","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1002\/hbm.25180","volume":"41","author":"AG de Lange","year":"2020","unstructured":"de Lange AG, Barth C, Kaufmann T, Maximov II, van der Meer D, Agartz I, et al. Women's brain aging: Effects of sex-hormone exposure, pregnancies, and genetic risk for Alzheimer's disease. Hum Brain Mapp. 2020;41(18):5141\u201350.","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"1121_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S2215-0366(15)00454-X","volume":"3","author":"CW Ritchie","year":"2016","unstructured":"Ritchie CW, Molinuevo JL, Truyen L, Satlin A, Van der Geyten S, Lovestone S. Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project. Lancet Psychiatry. 2016;3(2):179\u201386.","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"1121_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-021017","volume":"8","author":"A Solomon","year":"2019","unstructured":"Solomon A, Kivipelto M, Molinuevo JL, Tom B, Ritchie CW. European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJ Open. 2019;8(12):e021017.","journal-title":"BMJ Open"},{"key":"1121_CR32","doi-asserted-by":"crossref","unstructured":"Khan TK. Chapter 2 - Clinical Diagnosis of Alzheimer\u2019s Disease. In: Khan TK, editor. Biomarkers in Alzheimer's Disease: Academic Press; 2016. p. 27\u201348.","DOI":"10.1016\/B978-0-12-804832-0.00002-X"},{"issue":"2","key":"1121_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jalz.2016.07.154","volume":"13","author":"K Ritchie","year":"2017","unstructured":"Ritchie K, Ropacki M, Albala B, Harrison J, Kaye J, Kramer J, et al. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project. Alzheimers Dement. 2017;13(2):186\u201395.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1121_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S1355617713001094","volume":"20","author":"JH Kramer","year":"2014","unstructured":"Kramer JH, Mungas D, Possin KL, Rankin KP, Boxer AL, Rosen HJ, et al. NIH EXAMINER: conceptualization and development of an executive function battery. J Int Neuropsychol Soc. 2014;20(1):11\u20139.","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"1121_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","volume":"20","author":"C Randolph","year":"1998","unstructured":"Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20(3):310\u20139.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"1","key":"1121_CR36","first-page":"8","volume":"7","author":"CW Ritchie","year":"2020","unstructured":"Ritchie CW, Muniz-Terrera G, Kivipelto M, Solomon A, Tom B, Molinuevo JL. The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0. J Prev Alzheimers Dis. 2020;7(1):8\u201313.","journal-title":"J Prev Alzheimers Dis"},{"issue":"8","key":"1121_CR37","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/arclin\/act057","volume":"28","author":"S Karantzoulis","year":"2013","unstructured":"Karantzoulis S, Novitski J, Gold M, Randolph C. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease. Arch Clin Neuropsychol. 2013;28(8):837\u201344.","journal-title":"Arch Clin Neuropsychol"},{"issue":"8","key":"1121_CR38","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/hipo.22417","volume":"25","author":"K Moodley","year":"2015","unstructured":"Moodley K, Minati L, Contarino V, Prioni S, Wood R, Cooper R, et al. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory. Hippocampus. 2015;25(8):939\u201351.","journal-title":"Hippocampus."},{"key":"1121_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cortex.2015.03.016","volume":"67","author":"S Tu","year":"2015","unstructured":"Tu S, Wong S, Hodges JR, Irish M, Piguet O, Hornberger M. Lost in spatial translation - A novel tool to objectively assess spatial disorientation in Alzheimer's disease and frontotemporal dementia. Cortex. 2015;67:83\u201394.","journal-title":"Cortex."},{"issue":"7","key":"1121_CR40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/alz.12292","volume":"17","author":"S Ingala","year":"2021","unstructured":"Ingala S, De Boer C, Masselink LA, Vergari I, Lorenzini L, Blennow K, et al. Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort. Alzheimers Dement. 2021;17(7):1189\u2013204.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1121_CR41","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3174\/ajnr.A4169","volume":"36","author":"FD Raslau","year":"2015","unstructured":"Raslau FD, Mark IT, Klein AP, Ulmer JL, Mathews V, Mark LP. Memory part 2: the role of the medial temporal lobe. AJNR Am J Neuroradiol. 2015;36(5):846\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1121_CR42","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences: Routledge; 2013.","DOI":"10.4324\/9780203771587"},{"issue":"1","key":"1121_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000521898","volume":"51","author":"SE O'Bryant","year":"2022","unstructured":"O'Bryant SE, Barber RC, Philips N, Johnson LA, Hall JR, Subasinghe K, et al. The Link between APOE4 Presence and Neuropsychological Test Performance among Mexican Americans and Non-Hispanic Whites of the Multiethnic Health & Aging Brain Study - Health Disparities Cohort. Dement Geriatr Cogn Disord. 2022;51(1):26\u201331.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"1121_CR44","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1038\/s41598-021-86397-7","volume":"11","author":"KJ Anstey","year":"2021","unstructured":"Anstey KJ, Peters R, Mortby ME, Kiely KM, Eramudugolla R, Cherbuin N, et al. Association of sex differences in dementia risk factors with sex differences in memory decline in a population-based cohort spanning 20\u201376 years. Sci Rep. 2021;11(1):7710.","journal-title":"Sci Rep"},{"issue":"S5","key":"1121_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/alz.041482","volume":"16","author":"ER Mahoney","year":"2020","unstructured":"Mahoney ER, Dumitrescu L, Maki PM, Rapp SR, Keene CD, Corrada MMM, et al. Menopausal hormone therapy has beneficial effects on cognitive trajectories among homozygous carriers of the APOE-\u03b54 allele. Alzheimers Dementia. 2020;16(S5):e041482.","journal-title":"Alzheimers Dementia"},{"issue":"8","key":"1121_CR46","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1745-7254.2007.00618.x","volume":"28","author":"Y Yue","year":"2007","unstructured":"Yue Y, Hu L, Tian QJ, Jiang JM, Dong YL, Jin ZY, et al. Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes. Acta Pharmacol Sin. 2007;28(8):1129\u201335.","journal-title":"Acta Pharmacol Sin"},{"key":"1121_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1109\/RBME.2018.2796598","volume":"11","author":"S Leandrou","year":"2018","unstructured":"Leandrou S, Petroudi S, Kyriacou PA, Reyes-Aldasoro CC, Pattichis CS. Quantitative MRI Brain Studies in Mild Cognitive Impairment and Alzheimer's Disease: A Methodological Review. IEEE Rev Biomed Eng. 2018;11:97\u2013111.","journal-title":"IEEE Rev Biomed Eng"},{"issue":"48","key":"1121_CR48","doi-asserted-by":"publisher","first-page":"15223","DOI":"10.1523\/JNEUROSCI.3252-09.2009","volume":"29","author":"AM Fjell","year":"2009","unstructured":"Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, et al. One-year brain atrophy evident in healthy aging. J Neurosci. 2009;29(48):15223\u201331.","journal-title":"J Neurosci"},{"issue":"2","key":"1121_CR49","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1515\/revneuro-2015-0019","volume":"27","author":"M Zhou","year":"2016","unstructured":"Zhou M, Zhang F, Zhao L, Qian J, Dong C. Entorhinal cortex: a good biomarker of mild cognitive impairment and mild Alzheimer\u2019s disease. Rev Neurosci. 2016;27(2):185\u201395.","journal-title":"Rev Neurosci"},{"issue":"5","key":"1121_CR50","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0197-4580(01)00271-8","volume":"22","author":"BC Dickerson","year":"2001","unstructured":"Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, Bennett DA, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer\u2019s disease\u2606\u2606This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. Neurobiol Aging. 2001;22(5):747\u201354.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1121_CR51","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.neuroimage.2008.03.039","volume":"41","author":"AC Burggren","year":"2008","unstructured":"Burggren AC, Zeineh MM, Ekstrom AD, Braskie MN, Thompson PM, Small GW, et al. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage. 2008;41(4):1177\u201383.","journal-title":"Neuroimage."},{"issue":"1","key":"1121_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1148\/radiol.13131041","volume":"271","author":"CA Hostage","year":"2014","unstructured":"Hostage CA, Choudhury KR, Murali Doraiswamy P, Petrella JR. Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network. Radiology. 2014;271(1):211\u20139.","journal-title":"Radiology."},{"issue":"3","key":"1121_CR53","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1148\/radiol.10100307","volume":"258","author":"MV Spampinato","year":"2011","unstructured":"Spampinato MV, Rumboldt Z, Hosker RJ, Mintzer JE. Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology. 2011;258(3):843\u201352.","journal-title":"Radiology."},{"issue":"11","key":"1121_CR54","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00234-016-1740-8","volume":"58","author":"MV Spampinato","year":"2016","unstructured":"Spampinato MV, Langdon BR, Patrick KE, Parker RO, Collins H, Pravata\u2019 E, et al. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer\u2019s disease. Neuroradiology. 2016;58(11):1143\u201351.","journal-title":"Neuroradiology."},{"issue":"9","key":"1121_CR55","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/WNL.0000000000002970","volume":"87","author":"K Kantarci","year":"2016","unstructured":"Kantarci K, Tosakulwong N, Lesnick TG, Zuk SM, Gunter JL, Gleason CE, et al. Effects of hormone therapy on brain structure: A randomized controlled trial. Neurology. 2016;87(9):887\u201396.","journal-title":"Neurology."},{"issue":"2","key":"1121_CR56","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1212\/01.wnl.0000339037.76336.cf","volume":"72","author":"SM Resnick","year":"2009","unstructured":"Resnick SM, Espeland MA, Jaramillo SA, Hirsch C, Stefanick ML, Murray AM, et al. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology. 2009;72(2):135\u201342.","journal-title":"Neurology."},{"issue":"5","key":"1121_CR57","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1162\/jocn_a_00200","volume":"24","author":"PK Pilly","year":"2012","unstructured":"Pilly PK, Grossberg S. How do spatial learning and memory occur in the brain? Coordinated learning of entorhinal grid cells and hippocampal place cells. J Cogn Neurosci. 2012;24(5):1031\u201354.","journal-title":"J Cogn Neurosci"},{"key":"1121_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2022.102948","volume":"238","author":"L Quadt","year":"2022","unstructured":"Quadt L, Critchley H, Nagai Y. Cognition, emotion, and the central autonomic network. Auton Neurosci. 2022;238:102948.","journal-title":"Auton Neurosci"},{"key":"1121_CR59","doi-asserted-by":"crossref","unstructured":"Raine PJ, Rao H. Volume, density, and thickness brain abnormalities in mild cognitive impairment: an ALE meta-analysis controlling for age and education. Brain Imaging Behav.\u00a02022;16(5):2335\u201352.","DOI":"10.1007\/s11682-022-00659-0"},{"issue":"5","key":"1121_CR60","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s11682-020-00434-z","volume":"15","author":"Q Feng","year":"2021","unstructured":"Feng Q, Niu J, Wang L, Pang P, Wang M, Liao Z, et al. Comprehensive classification models based on amygdala radiomic features for Alzheimer\u2019s disease and mild cognitive impairment. Brain Imaging Behav. 2021;15(5):2377\u201386.","journal-title":"Brain Imaging Behav"},{"issue":"1","key":"1121_CR61","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/ijms22010373","volume":"22","author":"WJ Hwang","year":"2021","unstructured":"Hwang WJ, Lee TY, Kim NS, Kwon JS. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. Int J Mol Sci. 2021;22(1):373.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1121_CR62","first-page":"1952","volume":"98","author":"DB Dubal","year":"2001","unstructured":"Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, et al. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A. 2001;98(4):1952\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1121_CR63","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11682-019-00245-x","volume":"14","author":"CC Hays","year":"2020","unstructured":"Hays CC, Zlatar ZZ, Meloy MJ, Bondi MW, Gilbert PE, Liu T, et al. Interaction of APOE, cerebral blood flow, and cortical thickness in the entorhinal cortex predicts memory decline. Brain Imaging Behav. 2020;14(2):369\u201382.","journal-title":"Brain Imaging Behav"},{"issue":"11","key":"1121_CR64","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1177\/0271678X211020863","volume":"41","author":"ME Dounavi","year":"2021","unstructured":"Dounavi ME, Low A, McKiernan EF, Mak E, Muniz-Terrera G, Ritchie K, et al. Evidence of cerebral hemodynamic dysregulation in middle-aged APOE \u03b54 carriers: The PREVENT-Dementia study. J Cereb Blood Flow Metab. 2021;41(11):2844\u201355.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1121_CR65","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archneurol.2009.913","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Beason-Held L, An Y, Kraut MA, Resnick SM. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol. 2010;67(1):93\u20138.","journal-title":"Arch Neurol"},{"issue":"4","key":"1121_CR66","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3233\/JAD-121897","volume":"34","author":"CE Wierenga","year":"2013","unstructured":"Wierenga CE, Clark LR, Dev SI, Shin DD, Jurick SM, Rissman RA, et al. Interaction of age and APOE genotype on cerebral blood flow at rest. J Alzheimers Dis. 2013;34(4):921\u201335.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"1121_CR67","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1161\/ATVBAHA.107.145383","volume":"27","author":"A Sherwood","year":"2007","unstructured":"Sherwood A, Bower JK, McFetridge-Durdle J, Blumenthal JA, Newby LK, Hinderliter AL. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol. 2007;27(8):1782\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1121_CR68","doi-asserted-by":"crossref","unstructured":"Blackwell JA, Silva JF, Louis EM, Savu A, Largent-Milnes TM, Brooks HL, et al. Cerebral arteriolar and neurovascular dysfunction after chemically-induced menopause in mice. Am J Physiol Heart Circ Physiol.\u00a02022;323(5):H845\u2013h60.","DOI":"10.1152\/ajpheart.00276.2022"},{"issue":"8","key":"1121_CR69","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/cercor\/bhl103","volume":"17","author":"CR Mondadori","year":"2007","unstructured":"Mondadori CR, de Quervain DJ, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF, et al. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex. 2007;17(8):1934\u201347.","journal-title":"Cereb Cortex"},{"key":"1121_CR70","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuroimage.2012.10.010","volume":"65","author":"JM Rusted","year":"2013","unstructured":"Rusted JM, Evans SL, King SL, Dowell N, Tabet N, Tofts PS. APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures. NeuroImage. 2013;65:364\u201373.","journal-title":"NeuroImage."},{"issue":"1","key":"1121_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.6061\/clinics\/2012(01)03","volume":"67","author":"SS Mitter","year":"2012","unstructured":"Mitter SS, Ori\u00e1 RB, Kvalsund MP, Pamplona P, Joventino ES, Mota RM, et al. Apolipoprotein E4 influences growth and cognitive responses to micronutrient supplementation in shantytown children from northeast Brazil. Clinics (Sao Paulo). 2012;67(1):11\u20138.","journal-title":"Clinics (Sao Paulo)"},{"key":"1121_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-016-0194-x","volume":"8","author":"HN Yassine","year":"2016","unstructured":"Yassine HN, Rawat V, Mack WJ, Quinn JF, Yurko-Mauro K, Bailey-Hall E, et al. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease. Alzheimers Res Ther. 2016;8:25.","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"1121_CR73","doi-asserted-by":"publisher","first-page":"10315","DOI":"10.1096\/fj.201900423R","volume":"33","author":"A Martinsen","year":"2019","unstructured":"Martinsen A, Tejera N, Vauzour D, Harden G, Dick J, Shinde S, et al. Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice. FASEB J. 2019;33(9):10315\u201326.","journal-title":"FASEB J"},{"issue":"4","key":"1121_CR74","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11065-009-9118-x","volume":"19","author":"KM Rodrigue","year":"2009","unstructured":"Rodrigue KM, Kennedy KM, Park DC. Beta-amyloid deposition and the aging brain. Neuropsychol Rev. 2009;19(4):436\u201350.","journal-title":"Neuropsychol Rev"},{"issue":"6","key":"1121_CR75","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P. Neuroinflammation in Alzheimer's disease: Current evidence and future directions. Alzheimers Dement. 2016;12(6):719\u201332.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1121_CR76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2826.2006.01508.x","volume":"19","author":"BB Sherwin","year":"2007","unstructured":"Sherwin BB. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol. 2007;19(2):77\u201381.","journal-title":"J Neuroendocrinol"},{"issue":"12","key":"1121_CR77","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/gerona\/glp128","volume":"64","author":"MA Espeland","year":"2009","unstructured":"Espeland MA, Tindle HA, Bushnell CA, Jaramillo SA, Kuller LH, Margolis KL, et al. Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci. 2009;64(12):1243\u201350.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"15","key":"1121_CR78","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1001\/jamainternmed.2013.7727","volume":"173","author":"MA Espeland","year":"2013","unstructured":"Espeland MA, Shumaker SA, Leng I, Manson JE, Brown CM, LeBlanc ES, et al. Long-Term Effects on Cognitive Function of Postmenopausal Hormone Therapy Prescribed to Women Aged 50 to 55 Years. JAMA Intern Med. 2013;173(15):1429\u201336.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"1121_CR79","first-page":"838","volume":"72","author":"MA Espeland","year":"2017","unstructured":"Espeland MA, Rapp SR, Manson JE, Goveas JS, Shumaker SA, Hayden KM, et al. Long-term Effects on Cognitive Trajectories of Postmenopausal Hormone Therapy in Two Age Groups. J Gerontol A Biol Sci Med Sci. 2017;72(6):838\u201345.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1121_CR80","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ana.22239","volume":"69","author":"RA Whitmer","year":"2011","unstructured":"Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol. 2011;69(1):163\u20139.","journal-title":"Ann Neurol"},{"key":"1121_CR81","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2182","volume":"374","author":"Y Vinogradova","year":"2021","unstructured":"Vinogradova Y, Dening T, Hippisley-Cox J, Taylor L, Moore M, Coupland C. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases. BMJ. 2021;374:n2182.","journal-title":"BMJ."},{"issue":"7","key":"1121_CR82","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrendo.2015.82","volume":"11","author":"RD Brinton","year":"2015","unstructured":"Brinton RD, Yao J, Yin F, Mack WJ, Cadenas E. Perimenopause as a neurological transition state. Nat Rev Endocrinol. 2015;11(7):393\u2013405.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1121_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031267","volume":"7","author":"L Zhao","year":"2012","unstructured":"Zhao L, Morgan TE, Mao Z, Lin S, Cadenas E, Finch CE, et al. Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles. PLoS One. 2012;7(2):e31267.","journal-title":"PLoS One"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01121-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01121-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01121-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T10:27:48Z","timestamp":1673605668000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01121-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01121-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1853899\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"13 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a cross-sectional analysis of the online datasets of the EPAD LCS study. The studies involving human participants were reviewed and approved by the Independent Ethics Committee or other relevant ethical review board for written approval as required by local laws and regulations. A copy of approval is required by the University of Edinburgh as Sponsor before the study commences at each site. The study is designed and conducted in accordance with the guidelines for Good Clinical Practice (GCP), and with the ethical principles as proclaimed in the Declaration of Helsinki. All participants are required to provide written informed consent prior to participation in any research activities laid out in the EPAD LCS protocol. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}